FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

56 results

abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for the treatment of various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and certain pediatric patients.
abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients.
adalimumab
(adalimumab-fkjp)
Biocon Biologics Inc
Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).
adalimumab-ryvk
(adalimumab-ryvk)
Quallent Pharmaceuticals Health LLC
Usage: Adalimumab-ryvk is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and inhibit disease progression.
amjevita
(adalimumab-atto)
Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for various conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, either alone or in combination with other therapies.
budesonide
(budesonide)
Oceanside Pharmaceuticals
Usage: Budesonide rectal foam is indicated for inducing remission in patients with active mild to moderate distal ulcerative colitis, affecting areas up to 40 cm from the anal verge.
budesonide
(Budesonide)
Actavis Pharma, Inc.
Usage: Budesonide extended-release tablets are indicated for inducing remission in patients with active, mild to moderate ulcerative colitis.
cyltezo
(adalimumab-adbm)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.
depo-medrol
(methylprednisolone acetate)
Pharmacia & Upjohn Company LLC
Usage: DEPO-MEDROL is indicated for severe allergic states, dermatoses, endocrine and gastrointestinal disorders, hematologic conditions, certain neoplasms, and respiratory diseases. It also treats nervous system issues, renal problems, and rheumatic diseases. Additionally, it can be administered intra-articularly for arthritis and intralesionally for specific dermatologic conditions.
depo-medrol
(methylprednisolone acetate)
Pharmacia & Upjohn Company LLC
Usage: DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.

Medications for Ulcerative Colitis

abrilada

abrilada

adalimumab

adalimumab-ryvk

amjevita

budesonide

budesonide

cyltezo

depo-medrol

depo-medrol